Evidence map›Paper›PMID 24362816›Full record

ArticleNature genetics2014

Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database.

Bryony A Thompson, Amanda B Spurdle, John-Paul Plazzer, Marc S Greenblatt, Kiwamu Akagi, Fahd Al-Mulla, Bharati Bapat, Inge Bernstein, Gabriel Capellá, Johan T den Dunnen and 31 more

Abstract read
In one paragraph

Article in Nature genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 278 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
278citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

278 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Genotype-phenotype correlations inOncology reviews · 2025
    Pooled it
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Trial
  6. Characterisation of a Portuguese origin founder missense variant in MSH6.European journal of human genetics : EJHG · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. An accurate cellular assay to determine pathogenicity of coding and noncoding variants in Lynch syndrome genes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Therapeutic targeting of mismatch repair-deficient cancers.Nature reviews. Clinical oncology · 2025
    Review
  19. Genomic characterization of patients with colorectal cancer.Hereditary cancer in clinical practice · 2025
    Article
  20. Article

218 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors.

Bryony A Thompson *Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Amanda B Spurdle *Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
John-Paul PlazzerDepartment of Colorectal Medicine and Genetics, Royal Melbourne Hospital, Australia.
Marc S GreenblattVermont Cancer Center, University of Vermont College of Medicine, Burlington, VT, USA.
Kiwamu AkagiDivision of Molecular Diagnosis and Cancer Prevention, Saitama Cancer Center, Saitama, Japan.
Fahd Al-MullaDepartment of Pathology, Faculty of Medicine, Health Sciences Center, Kuwait University, Safat, Kuwait.
Bharati BapatDepartment of Lab Medicine and Pathobiology, University of Toronto, Canada.
Inge BernsteinDanish HNPCC Registry, Copenhagen, Denmark.
Gabriel CapelláHereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, Barcelona, Spain.
Johan T den DunnenCenter of Human and Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Desiree du SartMolecular Genetics Lab, Victorian Clinical Genetics Services, Murdoch Childrens Research Institute, Melbourne, Australia.
Aurelie FabreINSERM UMR S910, Department of Medical Genetics and Functional Genomics, Marseille, France.
Michael P FarrellDepartment of Cancer Genetics, Mater Private Hospital, Dublin, Ireland.
Susan M FarringtonColon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh, Scotland.
Ian M FraylingInstitute of Medical Genetics, University Hospital of Wales, Cardiff, UK.
Thierry FrebourgInserm U1079, Faculty of Medicine, Institute for Biomedical Research, University of Rouen, France.
David E GoldgarDepartment of Dermatology, University of Utah Medical School, Salt Lake City, UT, USA.
Christopher D HeinenCenter for Molecular Medicine, UConn Health Center, Farmington, CT, USA.
Elke Holinski-FederMGZ - Medizinisch Genetisches Zentrum, Munich, Germany.
Maija Kohonen-CorishSchool of Medicine, University of Western Sydney, Sydney, Australia.
Kristina Lagerstedt RobinsonDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Suet Yi LeungHereditary Gastrointestinal Cancer Genetic Diagnosis Laboratory, Department of Pathology, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong.
Alexandra MartinsInserm U1079, University of Rouen, Institute for Research and Innovation in Biomedicine, Rouen, France.
Pal MollerResearch Group on Inherited Cancer, Department of Medical Genetics, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.
Monika MorakMGZ - Medizinisch Genetisches Zentrum, Munich, Germany.
Minna NystromDivision of Genetics, Department of Biosciences, University of Helsinki, Helsinki, Finland.
Paivi PeltomakiDepartment of Medical Genetics, Haartman Institute, University of Helsinki, Finland.
Marta PinedaHereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, Barcelona, Spain.
Ming QiCenter for Genetic and Genomic Medicine, The First Affiliated Hospital of Zhejiang University School of Medicine, James Watson Institute of Genomic Sciences, Beijing Genome Institute, China.
Rajkumar RamesarMRC Human Genetics Research Unit, Division of Human Genetics, Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, South Africa.
Lene Juel RasmussenCenter for Healthy Aging, University of Copenhagen, Denmark.
Brigitte Royer-PokoraInstitute of Human Genetics, University of Düsseldorf, Germany.
Rodney J ScottDiscipline of Medical Genetics, Faculty of Health, University of Newcastle, The Hunter Medical Research Institute, NSW, Australia.
Rolf SijmonsDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Sean V TavtigianHuntsman Cancer Institute, Salt Lake City, UT, USA.
Carli M TopsCenter of Human and Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Thomas WeberState University of New York at Downstate, Brooklyn, NY, USA.
Juul WijnenCenter of Human and Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Michael O WoodsDiscipline of Genetics, Faculty of Medicine, Memorial University of Newfoundland, St. John's, NL, Canada.
Finlay MacraeDepartment of Colorectal Medicine and Genetics, Royal Melbourne Hospital, Australia.
Maurizio GenuardiDepartment of Biomedical, Experimental and Clinical Sciences, University of Florence, Italy.

Funding

The Role of CHFR in Tumorigenesis and Paclitaxel-Sensitivity in Breast CancerP50CA116201 · NCI · MAYO CLINIC ROCHESTER · PI PETER C LUCAS · 2005 to 2026
$49.9M
USC Consortium:Colorectal Cancer Family RegistryU01CA074799 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HAILE, ROBERT WILLIAM · 1997 to 2008
$20.4M
SEATTLE FAMILIAL COLORECTAL CANCER REGISTRYU01CA074794 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NEWCOMB, POLLY A · 1997 to 2007
$14.1M
ONTARIO REGISTRY FOR STUDIES OF FAMILIAL COLON CANCERU01CA074783 · NCI · CANCER CARE ONTARIO · PI GALLINGER, STEVEN · 1997 to 2008
$12.5M
Colon Cancer Family Registry CohortUM1CA167551 · NCI · STANFORD UNIVERSITY · PI HAILE, ROBERT WILLIAM, JENKINS, MARK A · 2013 to 2017
$11.3M
FAMILIAL COLORECTAL NEOPLASIA COLLABORATIVE GROUPU01CA074800 · NCI · MAYO CLINIC ROCHESTER · PI LINDOR, NORALANE MOREY · 1997 to 2007
$9.1M
The Colon Cancer Family Registry: USC ConsortiumU24CA074799 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HAILE, ROBERT WILLIAM · 2008 to 2011
$7.6M
The Colon Cancer Family Registry: SeattleU24CA074794 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NEWCOMB, POLLY A · 2008 to 2011
$7.0M
AUSTRALASIAN COLORECTAL CANCER FAMILY REGISTRYU01CA097735 · NCI · UNIVERSITY OF MELBOURNE · PI HOPPER, JOHN L · 2002 to 2007
$6.9M
The Colon Cancer Family Registry: AustralasiaU24CA097735 · NCI · UNIVERSITY OF MELBOURNE · PI HOPPER, JOHN L · 2008 to 2011
$6.2M
The Familial Colorectal Neoplasia Collaborative GroupU24CA074800 · NCI · MAYO CLINIC ROCHESTER · PI LINDOR, NORALANE MOREY, THIBODEAU, STEPHEN NORMAN · 2008 to 2011
$5.3M
The Colon Cancer Family Registry: OntarioU24CA074783 · NCI · CANCER CARE ONTARIO · PI GALLINGER, STEVEN · 2008 to 2011
$4.1M
Cancer Research UK 12076Medical Research Council MC_PC_U127527198Medical Research Council MC_U127527198Medical Research Council MR/K018647/1NCI NIH HHS 1R01CA164944NCI NIH HHS P50 CA116201NCI NIH HHS P50CA11620106NCI NIH HHS R01 CA115783NCI NIH HHS R01 CA115783-02NCI NIH HHS R01 CA164944NCI NIH HHS U01 CA074783NCI NIH HHS U01 CA074794NCI NIH HHS U01 CA074799NCI NIH HHS U01 CA074800NCI NIH HHS U01 CA097735NCI NIH HHS U24 CA074783NCI NIH HHS U24 CA074794NCI NIH HHS U24 CA074799NCI NIH HHS U24 CA074800NCI NIH HHS U24 CA097735NCI NIH HHS UM1 CA167551Wellcome Trust 090532Worldwide Cancer Research 12-1087
6 · The paper itself

Abstract

The clinical classification of hereditary sequence variants identified in disease-related genes directly affects clinical management of patients and their relatives. The International Society for Gastrointestinal Hereditary Tumours (InSiGHT) undertook a collaborative effort to develop, test and apply a standardized classification scheme to constitutional variants in the Lynch syndrome-associated genes MLH1, MSH2, MSH6 and PMS2. Unpublished data submission was encouraged to assist in variant classification and was recognized through microattribution. The scheme was refined by multidisciplinary expert committee review of the clinical and functional data available for variants, applied to 2,360 sequence alterations, and disseminated online. Assessment using validated criteria altered classifications for 66% of 12,006 database entries. Clinical recommendations based on transparent evaluation are now possible for 1,370 variants that were not obviously protein truncating from nomenclature. This large-scale endeavor will facilitate the consistent management of families suspected to have Lynch syndrome and demonstrates the value of multidisciplinary collaboration in the curation and classification of variants in public locus-specific databases.

Indexed as

Databases, GeneticClassificationDisease ManagementDNA Mismatch RepairGastrointestinal NeoplasmsGenetic VariationHumans

Identifiers

PMID24362816
PMCPMC4294709

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.